Distinctive inhibitory mechanisms of age and relative visceral adiposity on growth hormone secretion in pre- and postmenopausal women studied under a hypogonadal clamp

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 11, 2005, Pages 6006-6013

  Veldhuis, Johannes D ^a   Erickson, Dana ^a   Mielke, Kristi ^a   Farhy, Leon S ^b   Keenan, Daniel M ^b   Bowers, Cyril Y ^c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GONADORELIN AGONIST; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PRALMORELIN; SEX HORMONE; SODIUM CHLORIDE; SOMATOMEDIN C;

ADULT; AGED; AGING; ARTICLE; ATTENUATION; BLOOD SAMPLING; BODY FAT; CLAMP; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOWN REGULATION; FEEDBACK SYSTEM; FEMALE; GROWTH HORMONE RELEASE; HORMONE DEFICIENCY; HUMAN; HYPOGONADISM; NORMAL HUMAN; OBESITY; OVARY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; STATISTICS; STIMULATION; VISCERA; WAVEFORM;

ADIPOSITY; ADULT; AGE FACTORS; AGED; ARGININE; FEMALE; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; VISCERA;

EID: 27744552856     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-0854     Document Type: Article

References (74)

1. Vahl N, Jorgensen JO, Skjaerback C, Veldhuis JD, Orskov H, Christiansen J 1997 Abdominal adiposity rather than age and sex predicts the mass and patterned regularity of growth hormone secretion in mid-life healthy adults. Am J Physiol 272:E1108-E1116
2. Zadik Z, Chalew SA, McCarter Jr RJ, Meistas M, Kowarski AA 1985 The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab 60:513-516
3. Vermeulen A, Verdonck L 1978 Sex hormone concentrations in post-menopausal women. Clin Endocrinol (Oxf) 9:59-66
4. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA 2000 Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 343:682-688
5. Ho KKY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO 1987 Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 64:51-58
6. Weltman A, Weltman JY, Hartman ML, Abbott RD, Rogol AD, Evans WS, Veldhuis JD 1994 Relationship between age, percentage body fat, fitness, and 24-hour growth hormone-release in healthy young adults: effects of gender. J Clin Endocrinol Metab 78:543-548
7. Shah N, Evans WS, Veldhuis JD 1999 Actions of estrogen on the pulsatile, nyctohemeral, and entropic modes of growth hormone secretion. Am J Physiol 276:R1351-R1358
8. Giustina A, Veldhuis JD 1998 Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717-797
9. Veldhuis JD, Roemmich JN, Richmond EJ, Rogol AD, Lovejoy JC, Sheffield-Moore M, Mauras N, Bowers CY 2005 Endocrine control of body composition in infancy, childhood and puberty. Endocr Rev 26:114-146
10. Veldhuis JD, Bowers CY 2003 Sex-steroid modulation of growth hormone (GH) secretory control: tripeptidyl ensemble regulation under dual feedback restraint by GH and IGF-I. Endocrine 22:25-40
11. Lieman HJ, Adel TE, Forst C, von Hagen S, Santoro N 2001 Effects of aging and estradiol supplementation on GH axis dynamics in women. J Clin Endocrinol Metab 86:3918-3923
12. Yen SSC, Vela P, Rankin J, Littell AS 1970 Hormonal relationships during the menstrual cycle. JAMA 211:1513-1517
13. Ovesen P, Vahl N, Fisker S, Veldhuis JD, Christiansen JS, Jorgensen JO 1998 Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the preovulatory interval in normal women. J Clin Endocrinol Metab 83:1662-1667
14. Faria ACS, Bekenstein LW, Booth Jr RA, Vaccaro VA, Asplin CM, Veldhuis JD, Thorner MO, Evans WS 1992 Pulsatile growth hormone release in normal women during the menstrual cycle. Clin Endocrinol (Oxf) 36:591-596
15. Evans WS, Sollenberger MJ, Booth Jr RA, Rogol AD, Urban RJ, Carlsen EC, Johnson ML, Veldhuis JD 1992 Contemporary aspects of discrete peak detection algorithms. II. The paradigm of the luteinizing hormone pulse signal in women. Endocr Rev 13:81-104
16. Frantz AG, Rabkin MT 1965 Effects of estrogen and sex difference on secretion of human growth hormone. J Clin Endocrinol Metab 25:1470-1480
17. Mauras N, Rogol AD, Veldhuis JD 1990 Increased hGH production rate after low-dose estrogen therapy in prepubertal girls with Turner's syndrome. Pediatr Res 28:626-630
18. Devesa J, Lois N, Arce V, Diaz MJ, Lima L, Tresguerres JA 1991 The role of sexual steroids in the modulation of growth hormone (GH) secretion in humans. J Steroid Biochem Mol Biol 40:165-173
19. Friend KE, Hartman ML, Pezzoli SS, Clasey JL, Thorner MO 1996 Both oral and transdermal estrogen increase growth hormone release in postmenopausal women-a clinical research center study. J Clin Endocrinol Metab 81:2250-2256
20. van Kesteren P, Lips P, Deville W, Popp-Snijders C, Asscheman H, Megens J, Gooren L 1996 The effect of one-year cross-sex hormonal treatment on bone metabolism and serum insulin-like growth factor-1 in transsexuals. J Clin Endocrinol Metab 81:2227-2232
21. Lissett CA, Shalet SM 2003 The impact of dose and route of estrogen administration on the somatotropic axis in normal women. J Clin Endocrinol Metab 88:4668-4672
22. Veldhuis JD, Evans WS, Bowers CY 2002 Impact of estradiol supplementation on dual peptidyl drive of growth-hormone secretion in postmenopausal women. J Clin Endocrinol Metab 87:859-866
23. Veldhuis JD, Evans WS, Bowers CY 2003 Estradiol supplementation enhances submaximal feedforward drive of growth hormone (GH) secretion by recombinant human GH-releasing hormone-1,44-amide in a putatively somatostatinwithdrawn milieu. J Clin Endocrinol Metab 88:5484-5489
24. Mulligan T, Iranmanesh A, Kerzner R, Demers LW, Veldhuis JD 1999 Two-week pulsatile gonadotropin releasing hormone infusion unmasks dual (hypothalamic and Leydig-cell) defects in the healthy aging male gonadotropic axis. Eur J Endocrinol 141:257-266
25. Pincus SM 2000 Irregularity and asynchrony in biologic network signals. Methods Enzymol 321:149-182
26. Pincus SM, Hartman ML, Roelfsema F, Thorner MO, Veldhuis JD 1999 Hormone pulsatility discrimination via coarse and short time sampling. Am J Physiol 277:E948-E957
27. Veldhuis JD, Straume M, Iranmanesh A, Mulligan T, Jaffe CA, Barkan A, Johnson ML, Pincus SM 2001 Secretory process regularity monitors neuroendocrine feedback and feedforward signaling strength in humans.AmJ Physiol 280:R721-R729
28. Keenan DM, Roelfsema F, Biermasz N, Veldhuis JD 2003 Physiological control of pituitary hormone secretory-burst mass, frequency and waveform: a statistical formulation and analysis. Am J Physiol 285:R664-R673
29. Keenan DM, Licinio J, Veldhuis JD 2001 A feedback-controlled ensemble model of the stress-responsive hypothalamo-pituitary-adrenal axis. Proc Natl Acad Sci USA 98:4028-4033
30. Keenan DM, Alexander SL, Irvine CHG, Clarke IJ, Canny BJ, Scott CJ, Tilbrook AJ, Turner AI, Veldhuis JD 2004 Reconstruction of in vivo timeevolving neuroendocrine dose-response properties unveils admixed deterministic and stochastic elements in interglandular signaling. Proc Natl Acad Sci USA 101:6740-6745
31. Faria ACS, Veldhuis JD, Thorner MO, Vance ML 1989 Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation ofGHsecretion by GH-releasing hormone and suppression with somatostatin. J Clin Endocrinol Metab 68:535-541
32. Keenan DM, Veldhuis JD 2001 Disruption of the hypothalamic luteinizing hormone pulsing mechanism in aging men. Am J Physiol 281:R1917-R1924
33. Veldhuis JD, Anderson SM, Kok P, Iranmanesh A, Frystyk J, Orskov H, Keenan DM 2004 Estradiol supplementation modulates growth hormone (GH) secretory-burst waveform and recombinant human insulin-like growth factor-I-enforced suppression of endogenously driven GH release in postmenopausal women. J Clin Endocrinol Metab 89:1312-1318
34. Erickson D, Keenan DM, Mielke K, Bradford K, Bowers CY, Miles JM, Veldhuis JD 2004 Dual secretagogue drive of burst-like growth hormone secretion in postmenopausal compared with premenopausal women studied under an experimental estradiol clamp. J Clin Endocrinol Metab 89:4746-4754
35. Guillaume V, Magnan E, Cataldi M, Dutour A, Sauze N, Renard M, Razafindraibe H, Conte-Devolx B, Deghenghi R, Lenaerts V 1994 Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology 135:1073-1076
36. Fletcher TP, Thomas GB, Clarke IJ 1996 Growth hormone-releasing and somatostatin concentrations in the hypophysial portal blood of conscious sheep during the infusion of growth hormone-releasing peptide-6. Dom Anim Endocrinol 13:251-258
37. Bowers CY, Granda-Ayala R 1996 GHRP-2, GHRH and SRIF interrelationships during chronic administration of GHRP-2 to humans. J Pediatr Endocrinol Metab 9(Suppl 3):261-270
38. Fairhall KM, Mynett A, Robinson IC 1995 Central effects of growth hormone releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action. J Endocrinol 144:555-560
39. Hataya Y, Akamizu T, Takaya K, Kanamoto N, Ariyasu H, Saijo M, Moriyama K, Shimatsu A, Kojima M, Kangawa K, Nakao K 2001 A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GHreleasing hormone in humans. J Clin Endocrinol Metab 86:4552
40. Arvat E, Maccario M, Di Vito L, Broglio F, Benso A, Gottero C, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, Ghigo E 2001 Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 86:1169-1174
41. Sato M, Chihara K, Kita T, Kashio Y, Okimura Y, Kitajima N, Fujita T 1989 Physiological role of somatostatin-mediated autofeedback regulation for growth hormone: importance of growth hormone in triggering somatostatin release during a trough period of pulsatile growth hormone release in conscious male rats. Neuroendocrinol 50:139-151
42. Farhy LS, Straume M, Johnson ML, Kovatchev BP, Veldhuis JD 2001 A construct of interactive feedback control of the GH axis in the male. Am J Physiol 281:R38-R51
43. Farhy LS, Straume M, Johnson ML, Kovatchev B, Veldhuis JD 2002 Unequal autonegative feedback by GH models the sexual dimorphism in GH secretory dynamics. Am J Physiol 282:R753-R764
44. Farhy LS, Veldhuis JD 2003 Joint pituitary-hypothalamic and intrahypothalamic autofeedback construct of pulsatile growth hormone secretion. Am J Physiol 285:R1240-R1249
45. Farhy LS, Veldhuis JD 2004 Putative GH pulse renewal: periventricular somatostatinergic control of an arcuate-nuclear somatostatin and GH-releasing hormone oscillator. Am J Physiol 286:R1030-R1042
46. Anderson SM, Wideman L, Patrie JT, Weltman A, Bowers CY, Veldhuis JD 2001 Estradiol supplementation selectively relieves GH's autonegative feedback on GH-releasing peptide-2-stimulated GH secretion. J Clin Endocrinol Metab 86:5904-5911
47. Bray MJ, Vick TM, Shah N, Anderson SM, Rice LW, Iranmanesh A, Evans WS, Veldhuis JD 2001 Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion. J Clin Endocrinol Metab 86:3143-3149
48. Veldhuis JD, Patrie J, Wideman L, Patterson M, Weltman JY, Weltman A 2004 Contrasting negative-feedback control of endogenously driven and exercisestimulated pulsatile growth hormone secretion in women and men. J Clin Endocrinol Metab 89:840-846
49. Kuehl RO 1994 Split-plot designs. In: Statistical principles of research design and analysis. Belmont, CA: Duxbury Press; 473-498
50. Fisher LD, van Belle G 1996 Descriptive statistics. In: Biostatistics: a methodology for the health sciences. New York: Wiley & Sons; 58-74
51. O'Brien P 2002 Comparing two samples: extensions of the t, rank-sum, and log-rank tests. J Am Stat Assoc 83:51-61
52. Veldhuis JD, Bidlingmaier M, Anderson SM, Wu Z, Strassburger CJ 2001 Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-peg), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatile GH release in healthy women and men. J Clin Endocrinol Metab 86:3304-3310
53. Farhy LS, Veldhuis JD 2005 Deterministic construct of amplifying actions of ghrelin on pulsatile GH secretion. Am J Physiol 288:R1649-R1663
54. Muller EE, Cella SG, Parenti M, Deghenghi R, Locatelli V, De Gennaro-Colonna V, Torsello A, Cocchi D 1995 Somatotropic dysregulation in old mammals. Horm Res 43:39-45
55. Veldhuis JD, Anderson SM, Patrie JT, Bowers CY 2004 Estradiol supplementation in postmenopausal women doubles rebound-like release of growth hormone (GH) triggered by sequential infusion and withdrawal of somatostatin: evidence that estrogen facilitates endogenous GH-releasing hormone drive. J Clin Endocrinol Metab 89:121-127
56. Godfrey P, Rahal JO, Beamer WG, Copeland NG, Jenkins NA, Mayo KE 1993 GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat Genet 4:227-232
57. Low MJ, Otero-Corchon V, Parlow AF, Ramirez JL, Kumar U, Patel YC, Rubinstein M 2001 Somatostatin is required for masculinization of growth hormone-regulated hepatic gene expression but not of somatic growth. J Clin Invest 107:1571-1580
58. Shuto Y, Shibasaki T, Otagiri A, Kuriyama H, Ohata H, Tamura H, Kamegai J, Sugihara H, Oikawa S, Wakabayashi I 2002 Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J Clin Invest 109:1429-1436
59. Tannenbaum GS, Epelbaum J, Bowers CY 2003 Interrelationship between the novel peptide ghrelin, somatostatin and growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion. Endocrinology 144:967-974
60. Bowers CY 2002 New insight into the control of growth hormone secretion. In: Kleinberg DL, Clemmons DR, eds. Central and peripheral mechanisms in pituitary disease. Bristol, UK: BioScientifica; 163-175
61. Arvat E, Ceda GP, Di Vito L, Ramunni J, Gianotti L, Ghigo E 1998 Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRP's in human aging. Pituitary 1:51-58
62. Gianotti L, Maccario M, Lanfranco F, Ramunni J, Di Vito L, Grottoli S, Mueller EE, Ghigo E, Arvat E 2000 Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans. J Clin Endocrinol Metab 85:3604-3608
63. Alba-Roth J, Muller OA, Schopohl J, Von Werder K 1988 Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J Clin Endocrinol Metab 67:1186-1189
64. Anderson SM, Shah N, Evans WS, Patrie JT, Bowers CY, Veldhuis JD 2001 Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women. J Clin Endocrinol Metab 86:551-560
65. Bowers CY, Granda R, Mohan S, Kuipers J, Baylink D, Veldhuis JD 2004 Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GHreleasing peptide-2 in older men and women. J Clin Endocrinol Metab 89:2290-2300
66. Erickson D, Keenan DM, Farhy LS, Mielke K, Bowers CY, Veldhuis JD 2005 Determinants of dual secretagogue drive of burst-like GH secretion in premenopausal women studied under a selective estradiol clamp. J Clin Endocrinol Metab 90:1741-1751
67. Iranmanesh A, South S, Liem AY, Clemmons D, Thorner MO, Weltman A, Veldhuis JD 1998 Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men. Eur J Endocrinol 139:59-71
68. Hartman ML, Pincus SM, Johnson ML, Matthews DH, Faunt LM, Vance ML, Thorner MO, Veldhuis JD 1994 Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release. J Clin Invest 94:1277-1288
69. Veldhuis JD, Metzger DL, Martha Jr PM, Mauras N, Kerrigan JR, Keenan B, Rogol AD, Pincus SM 1997 Estrogen and testosterone, but not a non-aromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. J Clin Endocrinol Metab 82:3414-3420
70. Shah N, Evans WS, Bowers CY, Veldhuis JD 1999 Tripartite neuroendocrine activation of the human growth-hormone (GH) axis in women by continuous 24-hour GH-releasing peptide (GHRP-2) infusion: pulsatile, entropic, and nyctohemeral mechanisms. J Clin Endocrinol Metab 84:2140-2150
71. Pincus SM, Keefe DL 1992 Quantification of hormone pulsatility via an approximate entropy algorithm. Am J Physiol 262:E741-E754
72. Richmond E, Rogol AD, Basdemir D, Veldhuis OL, Clarke W, Bowers CY, Veldhuis JD 2002 Accelerated escape from GH autonegative feedback in midpuberty in males: evidence for time-delimited GH-induced somatostatinergic outflow in adolescent boys. J Clin Endocrinol Metab 87:3837-3844
73. Yilmaz H, Ozgur K, Isikoglu M, Sonmez C, Uner M 2004 Bone resorption starts at 14 days of treatment with gonadotropin-releasing hormone agonist in in vitro fertilization cycles. Gynecol Endocrinol 19:40-46
74. Muller EE, Locatelli V, Cocchi D 1999 Neuroendocrine control of growth hormone secretion. Physiol Rev 79:511-607